01/02/2026
As we welcome the new year, we at Xstrahl are proud of the significant milestones we achieved in our mission to advance radiation medicine and expand patient impact. Our team has remained focused on bridging the gap between preclinical innovation and clinical excellence, ensuring that the latest research translates into impactful treatments.
In the preclinical sector, in addition to several SARRP installations, like the two most recent in Santiago and Hamburg, we introduced MuriSuite and Voxl, the next-generation software updates for the SARRP system, providing researchers with enhanced precision and workflow efficiency. Heading into 2026, this evolution in software will empower researchers to unlock the full potential of functional imaging, turning high-resolution data into the clinical breakthroughs of tomorrow.
On the clinical side, we continued to expand our global footprint with the installation of Xstrahl 200 systems in Spain, Sweden, and New Zealand, and beyond, and installed Xstrahl 300 systems at Mexico’s leading cancer care center to scale patient impact and established Italy’s first dedicated veterinary hospital installation to provide advanced radiation care for pets, growing our reach to 64 countries worldwide.
These achievements, coupled with the growing momentum for treating benign pain and the rediscovery of orthovoltage therapy highlighted at ASTRO, underscore the vital role of radiation medicine in modern healthcare.
Looking ahead to 2026, our goal remains steadfast, to impact as many lives as possible. We thank our partners and the global medical community for their continued trust as we work together to redefine the future of radiation therapy.
Happy New Year from the Xstrahl team!
